A doctoral fellowship cosponsored by the National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI) and the Food and Drug Administration (FDA), Office of Minority Health and Health Equity (OMHHE) is currently available. The newly established Genomic Science and Health Equity Fellowship Program will fund this doctoral fellowship. This program will prepare fellows to use genetic, genomic and pharmacogenomic approaches to advance minority health and health equity. Fellows will be trained in the research methodology and medical product development processes that facilitate the delivery of drugs, biologics and devices from the bench to the bedside. This fellowship program will provide fellows opportunities based upon the research conducted in the laboratories of the fellowship mentors to address basic, clinical, or social and behavioral research related to minority health and health disparities. The fellowship also strives to train a diverse group of scientists who engage in such genetic, genomic or pharmacogenomic research. The fellowship provides an opportunity to develop an interdisciplinary skill set that bridges disparities in minority health and translation of genomic, genetic and pharmacogenomic laboratory research in practice.
David Bodine, Ph.D. (NHGRI), Maria Rios, Ph.D. (FDA) and Kamille West, M.D. (NIH Clinical Center) will co-mentor the first fellow selected for this position. The fellow will pursue genomics research related to transfusion support for sickle cell disease (SCD), a major health disparity that primarily affects African Americans. The successful candidate will complete a research project to produce reference reagents for blood group genotyping, which will optimize transfusion support for patients with SCD.
To be eligible for postdoctoral training at the NIH and FDA, by May 2021, candidates must hold or obtain a Ph.D., M.D. or D.V.M. in medicine, human genetics, genomics, computational biology, cell or molecular biology, epidemiology, biostatistics or closely related areas and have fewer than five years of relevant research experience since receipt of most recent doctoral degree. Strong laboratory skills and some knowledge of statistics are required. Excellent communication skills and fluency in both spoken and written English are imperative. Candidates must be a U.S. citizen or a permanent resident to apply.
Applications will be accepted starting February 15, 2021 and will be screened on a rolling basis until the position is filled. The fellow is expected to start in summer or fall 2021.
Please submit the following to Jamil B. Scott, Ph.D., M.P.H. at NHGRIFDAFellowship@mail.nih.gov:
brief statement of research interests
names and contact information for two professional references
Additional Salary Information: Salary is determined by experience and years since most recent terminal degree. Salary follows postdoctoral pay ranges determined annually by the U.S. Department of Health and Human Services.
About NIH National Human Genome Research Institute & FDA Office of Minority Health and Health Equity
The National Human Genome Research Institute (NHGRI) was established originally as the National Center for Human Genome Research in 1989 to lead the International Human Genome Project. NHGRI is part of the National Institutes of Health (NIH), the nation’s medical research agency. NHGRI funds and conducts research to uncover the role that the genome plays in human health and disease. This research occurs across a spectrum: basic research to shed light on the structure and function of the genome; translational research to decipher the molecular bases of human diseases; and clinical research to establish how to use genomic information to advance medical care. NHGRI also supports exploration of the complex ethical, legal, and social implications of genomics, and is committed to ensuring that the knowledge and benefits generated from genomics research are disseminated widely, both to fuel current and future researchers and to benefit the general public and promote genomic literacy.
The Food and Drug Administration (FDA) is responsible for advancing the public health by helping to speed innovations that make medical products more effective, safer, and more affordable and by helping ...the public get the accurate, science-based information they need to use medical products and foods to maintain and improve their health. The FDA Office of Minority Health and Health Equity (OMHHE) serves to promote and protect the health of diverse populations through research and communication of science that addresses health disparities. The FDA OMHHE aims to: (1) increase the amount of clinical trial data available on racial and ethnic minorities; improve the data quality to determine how minorities react to medical products; and increase transparency and access to available data; (2) strengthen FDA’s ability to respond to minority health concerns and (3) promote health and safety communication to minority populations who often experience low health literacy and/or speak English as a second language.